Sign In
Buy ATR
$112.53
+0.350 (+0.312%)
At Close: Jun 03, 2026
Why AptarGroup (ATR) is a Top Growth Stock for the Long-Term
10:46am, Friday, 01'st Aug 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
AptarGroup (ATR) Beats Q2 Earnings and Revenue Estimates
07:16pm, Thursday, 31'st Jul 2025
AptarGroup (ATR) came out with quarterly earnings of $1.66 per share, beating the Zacks Consensus Estimate of $1.58 per share. This compares to earnings of $1.37 per share a year ago.
Aptar Reports Second Quarter 2025 Results
05:00pm, Thursday, 31'st Jul 2025
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports Second Quarter 2025 Results.
AptarGroup: Holding Steady Until Q2 Results
01:10pm, Wednesday, 30'th Jul 2025
AptarGroup has delivered steady, consistent revenue and margin growth, though it has underperformed the S&P 500 over the past decade. Gross profit margin and return on invested capital have improved r
3 Packaging Stocks to Keep an Eye on Amid Industry Challenges
11:55am, Wednesday, 30'th Jul 2025
Although weak demand and tariffs cloud the Zacks Containers - Paper and Packaging industry's near-term outlook, BXBLY, ATR and GEF are navigating the challenges well.
AptarGroup (ATR) Earnings Expected to Grow: Should You Buy?
11:01am, Thursday, 24'th Jul 2025
AptarGroup (ATR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rakovina Therapeutics KT-5000AI Program Yields Potent ATR Inhibitor Hits in Early Screening
04:00am, Wednesday, 23'rd Jul 2025
Compounds developed through collaboration with Variational AI show targeted activity Compounds developed through collaboration with Variational AI show targeted activity
Will AptarGroup (ATR) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Tuesday, 22'nd Jul 2025
AptarGroup (ATR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Aptar Declares Quarterly Dividend
05:00pm, Thursday, 10'th Jul 2025
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Declares Quarterly Dividend.
4 Stocks to Buy on Steady Rebound in Manufacturing Activity
09:16am, Monday, 07'th Jul 2025
Manufacturing rebounds on easing inflation and rising orders, stocks like ALLE, ATR, BWEN, and DXPE could benefit.
CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR
07:00am, Wednesday, 02'nd Jul 2025
PRINCETON, N.J. , July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions in the intensive care unit and cardia
Aptar Named One of the World's Most Sustainable Companies by TIME for Second Consecutive Year
05:00pm, Wednesday, 25'th Jun 2025
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Named One of the World's Most Sustainable Companies by TIME for Second Consecutive Year.
CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR
07:00am, Tuesday, 24'th Jun 2025
PRINCETON, N.J. , June 24, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using
Top 3 Earnings Growth Stocks for Investment
04:00pm, Monday, 23'rd Jun 2025
AEM, ATR, and VICI stand out with rising earnings forecasts and solid growth, pointing to bullish investor potential.
AptarGroup (ATR) Upgraded to Strong Buy: Here's Why
01:00pm, Friday, 20'th Jun 2025
AptarGroup (ATR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
